You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Arimidex

Showing 1 - 25 of 192
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Breast Cancer Trial (ARV-471, Anastrozole, Surgical resection of breast tumor)

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
    Clinical Trial Site
Jan 26, 2023

Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)

Recruiting
  • Breast Cancer
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Apr 29, 2022

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Hypogonadism Trial in Denver (Acyline, Placebo Gel, Placebo Tablet)

Recruiting
  • Hypogonadism
  • Denver, Colorado
    University of Colorado CCTSI CTRC
Apr 25, 2022

Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

Withdrawn
  • Solid Tumor
  • Advanced Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Dec 21, 2022

Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial (Ribociclib, Fulvestrant,

Not yet recruiting
  • Locoregional Recurrence
  • +2 more
  • (no location specified)
Jul 18, 2022

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Breast Cancer, Hormone Receptor Positive Tumor Trial in Tampa (Durvalumab, Anastrozole 1mg, Letrozole 2.5mg)

Terminated
Has Results
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
May 27, 2022

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Metastatic Breast Cancer Trial in Baltimore (Trastuzumab plus Pertuzumab, Hormonal Therapy with Anastrozole and Fulvestrant,

Terminated
Has Results
  • Metastatic Breast Cancer
  • Trastuzumab plus Pertuzumab
  • +2 more
  • Baltimore, Maryland
    University of Maryland Marlene & Stewart Greenebaum Cancer Cente
May 4, 2022

Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer Trial in Lexington (Anastrozole 1mg, Letrozole 2.5mg,

Recruiting
  • Breast Cancer
  • +3 more
  • Anastrozole 1mg
  • +3 more
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jan 3, 2022

Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Jan 11, 2022

Breast Cancer Trial in Australia, New Zealand (Pre-radiotherapy commencement of anastrozole, Radiotherapy, Post radiotherapy

Active, not recruiting
  • Breast Cancer
  • Pre-radiotherapy commencement of anastrozole
  • +2 more
  • Canberra, Australian Capital Territory, Australia
  • +33 more
Nov 16, 2022

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-negative Breast Cancer
  • +6 more
  • Baltimore, Maryland
    University of Maryland Baltimore
Apr 29, 2022

Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)

Active, not recruiting
  • Breast Cancer
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital
Sep 16, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

DCIS Trial in Orange (Anastrozole)

Completed
Has Results
  • DCIS
  • Orange, California
    Chao Family Comprehensive Cancer Center
Apr 19, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Breast Cancer Trial in Houston (Arimidex, Faslodex)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    Baylor College of Medicine
Jul 16, 2020

Pulmonary Arterial Hypertension Trial in United States (Anastrozole, Placebo Oral Tablet)

Active, not recruiting
  • Pulmonary Arterial Hypertension
  • Stanford, California
  • +6 more
Dec 3, 2021

Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

Recruiting
  • Recurrent Endometrial Carcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 28, 2021

Invasive Breast Cancer Trial in Kansas City (Fulvestrant, Anastrazole)

Active, not recruiting
Has Results
  • Invasive Breast Cancer
  • Kansas City, Kansas
    University of Kansas Medical Center
Apr 29, 2021